Cargando…
Liquid biopsy‐based targeted gene screening highlights tumor cell subtypes in patients with advanced prostate cancer
Prostate cancer (PCa) clinical heterogeneity underscores tumor heterogeneity, which may be best defined by cell subtypes. To test if cell subtypes contributing to progression can be assessed noninvasively, we investigated whether 14 genes representing luminal, neuroendocrine, and stem cells are dete...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652435/ https://www.ncbi.nlm.nih.gov/pubmed/36172886 http://dx.doi.org/10.1111/cts.13372 |